There are a number of techniques currently used by the pharmaceutical industry for particle size determination. However, most of these are applicable in a visible particle range (> 25 μm) and are ...

InProcess-LSP is a relatively new, dynamic organization launched in 2014. The company combines the expertise and experience of three Process Analytical Technology (PAT) scientists and is based at the ...

Metastasis is leading cause of cancer death. The essential step of metastasis is invasion. The actin cytoskeleton plays a pivotal role in invasion and is closely linked to endocytosis process. We ...

Malvern Panalytical’s recent peer-reviewed publication, Tailoring Lipid Nanoparticle Dimensions Through Manufacturing Processes, published in RSC Pharmaceutics, features both the NanoSight Pro ...

Estrogen receptor positive (ER+) metastatic breast cancer (MBC) is an incurable condition affecting approximately 168,000 women annually in the US. Fulvestrant, an Estrogen Receptor Degrader, is a ...

Nanomaterials are used in various fields due to their distinct size-dependent properties, and accurate characterization is essential to optimize and design them for specific applications. 1 For ...

Joseph Brealey has been a key member of NanoFCM’s research team for three years. With a background in biochemistry, Joseph focuses on the practical analysis of nanoparticles including extracellular ...

Oxford Nanoimaging (ONI), a leader in super-resolution microscopy, is revolutionizing lipid nanoparticle (LNP) analysis with the launch of the ONI Application Kit™: LNP Profiler, the first and only ...

Scientists have developed a nanoparticle that precisely delivers a metal-chelating agent to breast cancer cells, enhancing ...